Published: Mon, March 20, 2017
Medicine | By Megan Pierce

Analysts At Macquarie Research Maintained Beazley PLC (LON:BEZ) As Underperform

Analysts At Macquarie Research Maintained Beazley PLC (LON:BEZ) As Underperform

This was released in an analyst report on Monday morning. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. It now has negative earnings. It has outperformed by 1.63% the S&P500. Out of 8 Wall Street analysts rating Genomic Health, 3 give it "Buy", 1 "Sell" rating, while 4 recommend "Hold". Therefore 52% are positive.

The 52 week high of shares in Beazley PLC is 450.2 while the 52 week low for the company's shares is 313.9. The firm's 50 day moving average is GBX 264.84 and its 200 day moving average is GBX 250.19. Numis Securities maintained the shares of MTRO in report on Wednesday, February 22 with "Sell" rating. As per Friday, February 3, the company rating was maintained by Credit Suisse. Bernstein has "Market Perform" rating and GBX 4346 target.

Shares of BAE Systems plc (LON:BA) opened at 646.50 on Monday.

In other news, insider George Culmer sold 145,828 shares of the business's stock in a transaction that occurred on Monday, March 6th.

AstraZeneca PLC is a biopharmaceutical company. The company has market cap of 2.67 billion GBP. Its segments include Electronic Systems, which consist of the Company's United States and United Kingdom-based electronics activities; Cyber & Intelligence, which consists of its United States-based Intelligence & Security business and the United Kingdom-headquartered applied intelligence business; Platforms & Services (US), which produces combat vehicles, weapons and munitions; Platforms & Services (UK), which consist of its United Kingdom-based air, maritime, combat vehicle, munitions and shared services activities; Platforms & Services (International), which consist of the Company's businesses in Saudi Arabia, Australia and Oman, together with its interest in the MBDA joint venture, and headquarters, which comprises the Company's head office activities, together with approximately 49% interest in Air Astana. It is focused on retail and small and medium size commercial customers. Investment Management Of Virginia Llc owns 396,488 shares or 2.03% of their U.S. portfolio. Moreover, Emory University has 1.86% invested in the company for 64,147 shares. The California-based Wall Street Associates has invested 1.73% in the stock. Tributary Capital Management Llc, a Colorado-based fund reported 237,371 shares.

Since January 1, 0001, it had 0 buys, and 16 sales for $2.47 million activity. The lowest target is $25 while the high is $44. The stock's average target of $19.25 is -9.50% below today's ($21.27) share price. (NASDAQ:GHDX) earned "Hold" rating by Zacks on Thursday, August 6. The firm earned "Restricted" rating on Thursday, January 14 by Jefferies. Canaccord Genuity has "Buy" rating and $44 target. The firm now has an "outperform" rating on the mining company's stock. (NASDAQ:GHDX) on Wednesday, September 2 with "Underweight" rating. Piper Jaffray downgraded Quidel Corporation (NASDAQ:QDEL) on Friday, December 16 to "Neutral" rating. The stock has "Hold" rating by Canaccord Genuity on Wednesday, August 5.

Analysts await Quidel Corporation (NASDAQ:QDEL) to report earnings on April, 26. Finally, Deutsche Bank AG increased their target price on shares of Anglo American plc from GBX 965 ($11.80) to GBX 1,200 ($14.67) and gave the stock a "hold" rating in a report on Wednesday, November 16th. AZN's profit will be $802.87 million for 23.98 P/E if the $0.32 EPS becomes a reality.

Like this: